You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 117 No. 4, April 1981 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Anti-Pigment-Cell Factors and Mucocutaneous Candidiasis

James J. Nordlund, MD; Nancy Howanitz, MD; Jean Claude Bystryn, MD; Bernadette M. Forget, RN, MSN; Aaron B. Lerner, MD

Arch Dermatol. 1981;117(4):210-212.


Abstract



• Previous reports document the fact that some patients with mucocutaneous candidiasis and vitiligo have a complementfixing anti-pigment-cell factor in their serum. We examined sera from seven patients with mucocutaneous candidiasis without vitiligo. Three of the seven sera contained the anti-pigment-cell factor. We suggest that these anti-pigment-cell factors, which are most probably antibodies, are not cytotoxic for pigment cells and, thus, not the cause of vitiligo. The association of vitiligo and anti-pigment-cell factors with the syndrome of mucocutaneous candidiasis implicates the immune system as a causal factor of vitiligo.

(Arch Dermatol 1981;117:210-212)



Author Affiliations



From the Department of Dermatology, West Haven (Conn) Veterans Administration Medical Center (Dr Nordlund); the Department of Dermatology, Yale University School of Medicine, New Haven, Conn (Ms Forget and Dr Lerner); and the New York University Medical Center (Drs Howanitz and Bystryn).


Footnotes



Accepted for publication July 28, 1980.

Reprint requests to West Haven Veterans Administration Medical Center, West Haven, CT 06516 (Dr Nordlund).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vitiligo: It Is Important
Nordlund and Lerner
Arch Dermatol 1982;118:5-8.
ABSTRACT  

Antibodies to Melanocytes: Occurrence in Patients With Vitiligo and Chronic Mucocutaneous Candidiasis
Howanitz et al.
Arch Dermatol 1981;117:705-708.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.